TruGenomix Health Inc.
155 Gibbs Street, #559
Rockville, MD 20850
TruGenomix Health Inc. (TruGenomix) is developing a first-of-its-kind blood test to diagnose
post-traumatic stress disorder (PTSD). PTSD is a global health challenge with a prevalence as high as 10% of the global population. In addition, it is estimated that as many as 24 million U.S. citizens suffer from PTSD at any one time. The challenges of diagnosing and treating U.S. military members are
widely documented. Military members suffer an estimated prevalence PTSD of twice that of the general population, which has contributed to an alarming rate of 22 Veteran suicides per day on average. TruGenomix is a Service Disabled Veteran-Owned Small Business (SDVOSB) eligible
company with expertise in genomics research, biotechnology development, and regulatory
science. The TruGenomix team has more than forty years of combined health and scientific
research experience serving the U.S. military and Veteran community. The team also has
combined more than twenty years of regulatory experience at the FDA. TruGenomix will
leverage its experience to develop and commercialize a diagnostic test kit for PTSD with an
initial focused marketing to the U.S. Department of Defense (DoD) and U.S.